pyrroles has been researched along with Ambulation Disorders, Neurologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Healy, ME; Krajewski, KM; Lai, KC; Miksad, RA; Rojas, R; Stein, MC; Zhu, AX | 1 |
Barbosa, E; Christie, DK; Pannu, R; Singh, AK; Singh, I | 1 |
2 other study(ies) available for pyrroles and Ambulation Disorders, Neurologic
Article | Year |
---|---|
Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials, Phase III as Topic; Gait Disorders, Neurologic; Hepatitis, Autoimmune; Humans; Indoles; Liver Neoplasms; Male; Postural Balance; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Sensation Disorders; Sunitinib | 2009 |
Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
Topics: Animals; Atorvastatin; Blood-Brain Barrier; Chemotaxis, Leukocyte; Cytokines; Down-Regulation; Endothelial Cells; Female; Gait Disorders, Neurologic; Heptanoic Acids; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroprotective Agents; Paralysis; Pyrroles; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; rhoA GTP-Binding Protein; Spinal Cord; Spinal Cord Injuries; Terpenes; Treatment Outcome | 2007 |